Nalmafene: marketing ploy or alcohol treatment breakthrough?

‘A pill for every ill’ is the gist of the attacks levelled at nalmefene in the form of Selincro, a drug expected to extend the benefits of pharmacotherapy to drinkers not physically dependent or in need of detoxification – or for critics, to medicalise psychosocial dependence on shaky scientific grounds.
Source: Alcohol Research UK - Category: Addiction Authors: Tags: Findings Source Type: news